{"totalResults":4157,"results":[{"description":"An overview of recent research results and progress related to the prevention, early detection, and treatment of liver cancer, including research related to biomarkers, cirrhosis, and hepatitis infections. Selected NCI-supported programs that address liver cancer are also described.","title":"Advances in Liver Cancer Research - National Cancer Institute","contentType":"cgvArticle","url":"https://www.cancer.gov/types/liver/research"},{"description":"Liver cancer includes hepatocellular carcinoma and bile duct cancer (cholangiocarcinoma). Risk factors for HCC include chronic infection with hepatitis B or C and cirrhosis of the liver. Start here to find information on liver and bile duct cancer treatment, causes and prevention, screening, research, and statistics.","title":"Liver and Bile Duct Cancer\u2014Patient Version - National Cancer Institute","contentType":"cgvCancerTypeHome","url":"https://www.cancer.gov/types/liver"},{"description":"Liver cancer includes two major types: hepatocellular carcinoma (HCC) and intrahepatic bile duct cancer, also known as cholangiocarcinoma. Find evidence-based information on liver and bile duct cancer treatment, causes and prevention, screening, research, genomics and statistics.","title":"Liver and Bile Duct Cancer\u2014Health Professional Version - National Cancer Institute","contentType":"cgvCancerTypeHome","url":"https://www.cancer.gov/types/liver/hp"},{"description":"NCI supports clinical trials studying new and more effective ways to detect and treat cancer. Find clinical trials for liver cancer.","title":"Liver Cancer Clinical Trials - National Cancer Institute","contentType":"nciAppModulePage","url":"https://www.cancer.gov/about-cancer/treatment/clinical-trials/disease/liver-cancer"},{"description":"This page lists cancer drugs approved by the Food and Drug Administration (FDA) for liver cancer. The list includes generic names and brand names. The drug names link to NCI\u2019s Cancer Drug Information summaries.","title":"Drugs Approved for Liver Cancer - National Cancer Institute","contentType":"cgvArticle","url":"https://www.cancer.gov/about-cancer/treatment/drugs/liver"}]}